Biopharmaceutical venture capital is spurring innovation and economic growth


The biopharmaceutical ecosystem has helped make the U.S. the global leader in biomedical innovation today. An important part of this ecosystem is the thousands of small startup biopharmaceutical firms that explore new avenues of medical research. Venture capital is the financial lifeblood of these startups, and America’s biopharmaceutical companies play an important role in startup financing through investments made by their corporate venture capital (CVC) arms.

To spotlight the importance of venture investment in the biopharmaceutical ecosystem, PhRMA today released new data examining the impact of venture capital and small startup companies in the U.S. from 2000-2017.